Comparing Claritin-D 12 Hour vs Sudafed 12-Hour
Claritin-D 12 Hour (loratadine / pseudoephedrine) | Sudafed 12-Hour (pseudoephedrine) |
|
---|
Claritin-D 12 Hour (loratadine / pseudoephedrine) | Sudafed 12-Hour (pseudoephedrine) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Over-the-counter
Prescribed for Allergic Rhinitis, Nasal Congestion. Claritin-D 12 Hour may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Prescribed for Nasal Congestion. Sudafed 12-Hour may also be used for purposes not listed in this medication guide. |
Related suggestions Nasal Congestion
|
|||||||
More about Claritin-D 12 Hour (loratadine / pseudoephedrine) | More about Sudafed 12-Hour (pseudoephedrine) | ||||||||
Ratings & Reviews | |||||||||
Claritin-D 12 Hour has an average rating of 6.1 out of 10 from a total of 10 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 40% reported a negative effect. |
Sudafed 12-Hour has an average rating of 5.8 out of 10 from a total of 6 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Claritin-D 12 Hour side effects |
View all Sudafed 12-Hour side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Claritin-D 12 Hour prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
|
||||||||
Brand Names | |||||||||
Other loratadine / pseudoephedrine brands include: Alavert D-12 Hour Allergy and Sinus, AllerClear D-24 Hour, Allergy & Congestion Relief, Allergy Relief D 24 Hour, Allergy Relief D12, Claritin-D, Claritin-D 24 Hour, Clear-Atadine-D, Leader Allergy Relief D-24, Loratadine-D 12 Hour, Loratadine-D 24 Hour View more | Other pseudoephedrine brands include: 12 Hour Decongestant, 12 Hour Nasal Decongestant, Afrinol, Allermed, Cenafed, Children's Dimetapp Decongestant Infant, Chlor-Trimeton Nasal Decongestant, Contac Cold, Decofed, Decofed Liquid, Drixoral Decongestant Non-Drowsy, Efidac, Elixsure Decongestant, Entex, Genaphed, nasofed, Nexafed Nasal Decongestant, Novafed, Silfedrine, Sudafed 24-Hour, Sudafed Congestion, SudoGest, SudoGest 12 Hour, Suphedrin, Suphedrine, Zephrex-D View more | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
18 hours |
16 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 325 drugs are known to interact with Claritin-D 12 Hour:
|
A total of 220 drugs are known to interact with Sudafed 12-Hour:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
N/A |
October 31, 1991 |
||||||||
WADA Class View classifications | |||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
N/A |
N/A |
||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.